Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Psychiatric Disorders (Diagnosis)
Interventions
OTHER

Clinical and eye movements

"Eye tracking in virtual reality environment:~Clinical and psychometric assessment :~* Auto-assessment scales : State-Trait Anxiety Inventory (STAI-TRAIT/ STAI-STATE), Fagerström Test For Nicotine Dependance (FTND), Annett handedness questionnaire, Alcohol Use Disorders Identification Test (AUDIT), Substance Use Risk Profile Scale (SURPS)~* Hetero-assessment scales : Mini International Neuropsychiatric Interview (MINI DSM version 5), Young Mania Rating Scale (YMRS), Hamilton Depression Scale (HDRS), Positive And Negative Scale for Schizophrenia (PANSS)"

Trial Locations (1)

91 150

Etablissement Public de Santé Barthélemy Durand, Étampes

All Listed Sponsors
collaborator

Aix Marseille Université

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Hopital Paul Brousse

OTHER

lead

Etablissement Public de Santé Barthélemy Durand

OTHER

NCT07057024 - Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression | Biotech Hunter | Biotech Hunter